GCM
IART icon

Graham Capital Management’s Integra LifeSciences IART Stock Holding History

Graham Capital Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-24,105
Closed -$991K – 1141
2023
Q2 		$991K Buy
24,105
+18,233
+311% +$878K 0.03% 372
2023
Q1 		$337K Buy
+5,872
New +$331K 0.01% 859
2022
Q4 		– Sell
-8,184
Closed -$346K – 1164
2022
Q3 		$346K Sell
8,184
-28,708
-78% -$1.47M 0.01% 855
2022
Q2 		$1.99M Buy
+36,892
New +$2.22M 0.08% 210

Other funds holding IART

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Graham Capital Management's IART Position: Q3 2023 in Review

Graham Capital Management sold out of Integra LifeSciences (IART) in Q3 2023, closing a stake of 24,105 shares — an estimated $991K sold.

Graham Capital Management first reported a position in IART in Q2 2022 and held it in 4 quarters. The position peaked at $1.99M in Q2 2022. 262 funds tracked by Wall St. Rank hold IART as of Q3 2023.

  • Graham Capital Management reported no remaining Integra LifeSciences position as of Q3 2023 after selling out during the quarter.
  • Graham Capital Management sold 24,105 Integra LifeSciences shares in Q3 2023, an estimated $991K.
  • Graham Capital Management first reported a position in Integra LifeSciences in Q2 2022 and held it in 4 quarters.
  • Graham Capital Management's Integra LifeSciences position peaked at $1.99M in Q2 2022.
  • 262 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2023.

Based on Graham Capital Management's 13F filing for Q3 2023, filed 22 Nov 2023.